Evaluation of effect of charge and lipid coating on ability of 60-nm nanoparticles to cross an in vitro model of the blood-brain barrier.

A cell culture model of the blood-brain barrier (BBB) consisting of a coculture of bovine brain capillary endothelial cells and rat astrocytes has been used to examine the ability of 60-nm nanoparticles with different physicochemical characteristics to cross the BBB. Neutral, anionic, and cationic nanoparticles were made from crosslinked malto-dextrins derivatized or not (neutral) with phosphates (anionic), quaternary ammoniums (cationic) ligands. Then, these particles were coated or not with a lipid bilayer made of dipalmitoyl phosphatidyl choline and cholesterol. Lipid coating of ionically charged nanoparticles was able to increase BBB crossing 3- or 4-fold compared with uncoated particles, whereas coating of neutral particles did not significantly alter their permeation characteristics across the endothelial cell monolayer. Lipid-coated nanoparticles were nontoxic toward BBB integrity, and crossed the BBB by transcytosis without any degradation. Furthermore, a 27-fold increase in albumin transport was observed when albumin had previously been loaded in the cationic lipid-coated nanoparticles. The influence of red blood cells was studied; a marked inhibition of the transport was observed, probably due to strong interaction between nanoparticles and red blood cells.

• Publication year

  1999

• Venue

  Journal of Pharmacology and Experimental Therapeutics

• Publication date

  1999-12-01

• Fields of study

  Medicine, Materials Science, Chemistry

• Identifiers
  DOI 10.1016/s0022-3565(24)35204-8PMID 10565819
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Receptor-mediated Transcytosis of Lactoferrin through the Blood-Brain Barrier*

  1999cited by this paper
• Characterization and phase behaviour of phospholipid bilayers adsorbed on spherical polysaccharidic nanoparticles.

  1997cited by this paper
• Occludin as a possible determinant of tight junction permeability in endothelial cells.

  1997cited by this paper
• A New Function for the LDL Receptor: Transcytosis of LDL across the Blood–Brain Barrier

  1997influential reference
• Occludin is a functional component of the tight junction.

  1996cited by this paper
• Combination of human cytomegalovirus recombinant immediate-early protein (IE1) with 80 nm cationic biovectors: protection from proteolysis and potentiation of presentation to CD4+ T-cell clones in vitro.

  1996cited by this paper
• Receptor-mediated transcytosis of transferrin through blood-brain barrier endothelial cells.

  1996cited by this paper
• NEM inhibits transcytosis, endocytosis, and capillary permeability: implication of caveolae fusion in endothelia.

  1995cited by this paper
• Drug transport to the brain: comparison between in vitro and in vivo models of the blood-brain barrier

  1995cited by this paper
• A detergent-free method for purifying caveolae membrane from tissue culture cells.

  1995cited by this paper
• Distribution of nerve growth factor following direct delivery to brain interstitium.

  1995cited by this paper
• Albondin-mediated capillary permeability to albumin. Differential role of receptors in endothelial transcytosis and endocytosis of native and modified albumins.

  1994cited by this paper
• The aged monkey basal forebrain: rescue and sprouting of axotomized basal forebrain neurons after grafts of encapsulated cells secreting human nerve growth factor.

  1994cited by this paper
• Intracarotid infusion of RMP-7, a bradykinin analog: a method for selective drug delivery to brain tumors.

  1994cited by this paper
• Blood-brain barrier penetration and in vivo activity of an NGF conjugate.

  1993cited by this paper
• Pharmacologic effects in vivo in brain by vector-mediated peptide drug delivery.

  1993cited by this paper
• Gene therapy for neurologic disease.

  1993cited by this paper
• Update on the cellular and molecular basis of capillary permeability.

  1993cited by this paper
• Nerve growth factor affects11C-nicotine binding, blood flow, EEG, and verbal episodic memory in an Alzheimer patient (Case Report)

  1992cited by this paper
• Nerve growth factor affects 11C-nicotine binding, blood flow, EEG, and verbal episodic memory in an Alzheimer patient (case report).

  1992cited by this paper
• Transendothelial transport of serum albumin: a quantitative immunocytochemical study

  1992cited by this paper
• Drug Transfer Across the Blood‐Brain Barrier: Correlation Between In Vitro and In Vivo Models

  1992influential reference
• An Easier, Reproducible, and Mass‐Production Method to Study the Blood–Brain Barrier In Vitro

  1990cited by this paper
• [9] Liposome preparation and size characterization

  1989cited by this paper
• Permeability and Mechanism of Albumin, Cationized Albumin, and Glycosylated Albumin Transcellular Transport Across Monolayers of Cultured Bovine Brain Capillary Endothelial Cells

  1989cited by this paper
• Nerve growth factor in Alzheimer's disease: to treat or not to treat?

  1989cited by this paper
• Osmotic opening of the blood-brain barrier.

  1988cited by this paper
• Absence of albumin receptor on brain capillaries in vivo or in vitro.

  1985cited by this paper
• Effect of the nonionic surfactant poloxamer 338 on the fate and deposition of polystyrene microspheres following intravenous administration.

  1983cited by this paper
• Interaction of acidic liposomes with red blood cells. Induction of endocytosis and shedding of particles.

  1982cited by this paper
• Tritium labeling of proteins to high specific radioactivity by reduction methylation.

  1980cited by this paper
• Binding of positively charged particles to glutaraldehyde-fixed human erythrocytes.

  1972cited by this paper
• Studies of the steric stabilization of colloidal particles

  1971cited by this paper
• FINE STRUCTURAL LOCALIZATION OF A BLOOD-BRAIN BARRIER TO EXOGENOUS PEROXIDASE

  1967cited by this paper
• Phosphorus assay in column chromatography.

  1959cited by this paper
• Reconstituted rattail collagen used as substrate for tissue cultures on coverslips in Maximow slides and roller tubes.

  1958cited by this paper

• Positively Charged Polymers Based on Cyclodextrins for Trametinib and Selumetinib Delivery in Glioblastoma Cancer

  2026cites this paper
• From conventional therapy to treatment with lipid-polymer hybrid nanoparticles for hepatocellular carcinoma

  2025cites this paper
• Acid-Responsive Disassembly of Nanomedicines for Extracellular Drug Delivery Reversing Glioblastoma Immunosuppressive Microenvironment by Targeting the Adenosine-A2AR Pathway.

  2025cites this paper
• Topical and transdermal lipid-polymer hybrid nanoparticles (LPN): an integration in advancing dermatological treatments

  2025cites this paper
• Novel Cationic Bolaamphiphiles for Protein and DNA Binding, Gene Delivery, and Antimicrobial Applications.

  2025cites this paper
• Effect of Particle Size versus Surface Charge on the Brain Targeting Behaviour of Elastic Nanovesicles: In-Vitro Characterization, Comparison between I-optimal and D-optimal Statistical Optimization and In-vivo Pharmacokinetic Evaluation

  2024cites this paper
• Highlights on Cell-Penetrating Peptides and Polymer-Lipid Hybrid Nanoparticle: Overview and Therapeutic Applications for Targeted Anticancer Therapy

  2023cites this paper
• Red Blood Cell Sublethal Damage: Hemocompatibility Is not the Absence of Hemolysis.

  2023cites this paper
• Nanomaterials as drug delivery agents for overcoming the blood-brain barrier: A comprehensive review

  2023cites this paper
• Nano‐therapeutic strategies to target coronavirus

  2021cites this paper
• Chitosan-alginate core-shell-corona shaped nanoparticles of dimethyl fumarate in orodispersible film to improve bioavailability in treatment of multiple sclerosis: Preparation, characterization and biodistribution in rats

  2021cites this paper
• Central nervous system delivery of molecules across the blood-brain barrier.

  2021cites this paper
• Gold Derivatives Development as Prospective Anticancer Drugs for Breast Cancer Treatment

  2021cites this paper
• Surface charge, glycocalyx, and blood-brain barrier function

  2021cites this paper
• Development of a dry powder for inhalation of nanoparticles codelivering cisplatin and ABCC3 siRNA in lung cancer.

  2021cites this paper
• Drug Delivery Strategies for Curcumin and Other Natural Nrf2 Modulators of Oxidative Stress-Related Diseases

  2021influential citation
• Emergence of Polymer-Lipid Hybrid Systems in Healthcare Scenario

  2021cites this paper
• Polymeric Nanoparticles for Nasal Drug Delivery to the Brain: Relevance to Alzheimer's Disease

  2020cites this paper
• Understanding the Uptake of Nanomedicines at Different Stages of Brain Cancer Using a Modular Nanocarrier Platform and Precision Bispecific Antibodies

  2020cites this paper
• New Nanomaterials and Techniques for Tumor-targeted Systems

  2020cites this paper
• Nanohybrid carriers: the yin-yang equilibrium between natural and synthetic in biomedicine.

  2020cites this paper
• Lipid-Based Tumor-targeted Systems

  2020cites this paper
• Nanophytomedicine: An Effective Way for Improving Drug Delivery and Bioavailability of Herbal Medicines

  2020cites this paper
• Nanocarrier-Mediated Drug Delivery Systems for Neurodegenerative Diseases

  2019cites this paper
• Mechanisms of Nanoparticle Toxicity in Cancer and Normal Cells

  2019cites this paper
• Lipid Based Nanoparticles: Current Strategies for Brain Tumor Targeting

  2019cites this paper
• The Strategies of Nanomaterials for Traversing Blood-Brain Barrier

  2019cites this paper
• Brain targeted delivery of anticancer drugs: prospective approach using solid lipid nanoparticles.

  2019cites this paper
• Development of injectable liposomes and drug‐in‐cyclodextrin‐in‐liposome formulations encapsulating estetrol to prevent cerebral ischemia of premature babies

  2019cites this paper
• Lipid–polymer hybrid nanoparticles as a next-generation drug delivery platform: state of the art, emerging technologies, and perspectives

  2019cites this paper
• Lipid-polymer hybrid nanocarrier-mediated cancer therapeutics: current status and future directions.

  2018cites this paper
• Directed Self-Assembly of Tethered Membranes on Nanoparticles

  2018cites this paper
• Brain Delivery of Multifunctional Dendrimer Protein Bioconjugates

  2018cites this paper
• Nanocarriers as a powerful vehicle to overcome blood-brain barrier in treating neurodegenerative diseases: Focus on recent advances

  2018cites this paper
• Chapter 2 Challenges for Nanoparticle Characterization

  2018cites this paper
• Dosimetry and Radioenhancement Comparison of Gold Nanoparticles in Kilovoltage and Megavoltage Radiotherapy using MAGAT Polymer Gel Dosimeter

  2018cites this paper
• Multifunctional Polymeric Enveloped Nanocarriers: Targeting Extracellular and Intracellular Barriers

  2018cites this paper
• Lipid‐polymer hybrid nanocarriers for delivering cancer therapeutics

  2018cites this paper
• Development of new amphiphilic bio-organic assemblies for potential applications in iron-binding and targeting tumor cells

  2018cites this paper
• Niosomes decorated with dual ligands targeting brain endothelial transporters increase cargo penetration across the blood‐brain barrier

  2018cites this paper
• Lipid polymer hybrid carrier systems for cancer targeting: A review

  2018cites this paper
• Advances in Personalized Nanotherapeutics

  2017influential citation
• Farnesylthiosalicylic acid‐loaded lipid–polyethylene glycol–polymer hybrid nanoparticles for treatment of glioblastoma

  2017cites this paper
• Identification of epidermal growth factor receptor-positive glioblastoma using lipid-encapsulated targeted superparamagnetic iron oxide nanoparticles in vitro

  2017cites this paper
• Effect of IL-1β, TNF-α and IGF-1 on trans-endothelial passage of synthetic vectors through an in vitro vascular endothelial barrier of striated muscle

  2017cites this paper
• Evaluation of the parameters of a bead milling process to produce a non-aqueous nanosuspension

  2017cites this paper
• Neuropathic Pain and Lung Delivery of Nanoparticulate Drugs: An Emerging Novel Therapeutic Strategy.

  2017cites this paper
• Sophorolipid Butyl Ester Diacetate Does Not Affect Macrophage Polarization but Enhances Astrocytic Glial Fibrillary Acidic Protein Expression at Micromolar Concentrations in Vitro.

  2017cites this paper
• Nanoformulations for dimethyl fumarate: Physicochemical characterization and in vitro/in vivo behavior

  2017cites this paper
• Biodegradable Polymeric Biomaterials in Different Forms for Long-acting Contraception and Drug Delivery to the Eye and Brain

  2017cites this paper
• Targeted Drug Delivery for Personalized Cure

  2017cites this paper
• Nanotechnology in Neuroscience and its Perspective as Gene Carrier.

  2017cites this paper
• In vitro models of the blood–brain barrier: An overview of commonly used brain endothelial cell culture models and guidelines for their use

  2016cites this paper
• Butylglyceryl-modified polysaccharide nanoparticles for drug delivery to the brain

  2016cites this paper
• Physicochemical properties of engineered nanomaterials that influence their nervous system distribution and effects.

  2016cites this paper
• Lipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come

  2016influential citation
• Role of Nanotechnology for Enzyme Replacement Therapy in Lysosomal Diseases. A Focus on Gaucher's Disease.

  2016cites this paper
• Drug–Targeting Strategies to CNS Disorders

  2016cites this paper
• Nanomedicines for the Eye: Current Status and Future Development

  2016cites this paper
• Pluronic P85-coated poly(butylcyanoacrylate) nanoparticles overcome phenytoin resistance in P-glycoprotein overexpressing rats with lithium-pilocarpine-induced chronic temporal lobe epilepsy.

  2016cites this paper
• In vitro blood-brain barrier models for drug research: state-of-the-art and new perspectives on reconstituting these models on artificial basement membrane platforms.

  2016cites this paper
• Nanocarriers for cancer-targeted drug delivery

  2016cites this paper
• Nanomedicine in Central Nervous System (CNS) Disorders: A Present and Future Prospective.

  2016cites this paper
• Blood-brain barrier co-culture models to study nanoparticle penetration: focus on co-culture systems

  2015cites this paper
• Polysorbate 80‐coated PLGA nanoparticles improve the permeability of acetylpuerarin and enhance its brain‐protective effects in rats

  2015cites this paper
• In vitro discrimination of the role of LRP1 at the BBB cellular level: focus on brain capillary endothelial cells and brain pericytes.

  2015cites this paper
• Understanding and exploiting nanoparticles' intimacy with the blood vessel and blood.

  2015cites this paper
• Transient and Local Increase in the Permeability of the Blood-Brain Barrier and the Blood-Retinal Barrier by Hyperthermia of Magnetic Nanoparticles in a Rat Model

  2015influential citation
• Emerging Use of Nanotechnology in the Treatment of Neurological Disorders.

  2015cites this paper
• Blood Brain Barrier: A Challenge for Effectual Therapy of Brain Tumors

  2015cites this paper
• Nanoparticles: Important Tools to Overcome the Blood–Brain Barrier and Their Use for Brain Imaging

  2015cites this paper
• Characterization of phospholipid-encapsulated gold nanoparticles: a versatile platform to study drug delivery and cellular uptake mechanisms

  2015cites this paper
• Nanotoxicity-Induced Alzheimer Disease and Parkinsonism: Not Further than Diagnosis

  2015cites this paper
• Xenobiotic pulmonary exposure and systemic cardiovascular response via neurological links.

  2015cites this paper
• Liprosomes loading paclitaxel for brain-targeting delivery by intravenous administration: in vitro characterization and in vivo evaluation.

  2014cites this paper
• Ear as an alternative way for brain drug targeting: An Overview

  2014cites this paper
• Solid lipid nanoparticles with surface antibody for targeting the brain and inhibiting lymphatic phagocytosis

  2014cites this paper
• Nanoparticles for Diagnosis and/or Treatment of Alzheimer's Disease

  2014cites this paper
• Nanoparticles in drug delivery: mechanism of action, formulation and clinical application towards reduction in drug-associated nephrotoxicity

  2014cites this paper
• Cell-Based in Vitro Blood–Brain Barrier Model Can Rapidly Evaluate Nanoparticles’ Brain Permeability in Association with Particle Size and Surface Modification

  2014cites this paper
• Nanoparticle enabled drug delivery across the blood brain barrier: in vivo and in vitro models, opportunities and challenges.

  2014cites this paper
• Merging the best of both worlds: hybrid lipid-enveloped matrix nanocomposites in drug delivery.

  2014cites this paper
• Brain tumor-targeted drug delivery strategies

  2014cites this paper
• Positive-charged solid lipid nanoparticles as paclitaxel drug delivery system in glioblastoma treatment.

  2014cites this paper
• Engineered nanoparticles. How brain friendly is this new guest?

  2014cites this paper
• Transport of Nanoparticles across Blood–Brain Barrier

  2013cites this paper
• Drug targeting to brain: a systematic approach to study the factors, parameters and approaches for prediction of permeability of drugs across BBB

  2013cites this paper
• Delivery of analgesic peptides to the brain by nano-sized bolaamphiphilic vesicles made of monolayer membranes.

  2013cites this paper
• Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.

  2013cites this paper
• Nanotechnology: Toxicologic Pathology

  2013cites this paper
• Metal-based nanoparticle interactions with the nervous system: the challenge of brain entry and the risk of retention in the organism.

  2013cites this paper
• Ability of plasmid DNA complexed with histidinylated lPEI and lPEI to cross in vitro lung and muscle vascular endothelial barriers.

  2013cites this paper
• Nanoparticle- and liposome-carried drugs: new strategies for active targeting and drug delivery across blood-brain barrier.

  2013cites this paper
• Advances in brain drug targeting and delivery: limitations and challenges of solid lipid nanoparticles

  2013cites this paper
• Influence of Nanomaterial and Technology on Cellular Structure and Signal Transduction

  2013cites this paper
• Application of Nanomaterial in Sports and its Safety Research

  2013cites this paper
• Medicinal Chemistry Based Approaches and Nanotechnology‐Based Systems to Improve CNS Drug Targeting and Delivery

  2013cites this paper
• A Big Response to a “Small” Problem: Identifying the Oxidative Potential of Nanomaterials and the Physicochemical Characteristics That Play a Role

  2012cites this paper
• Targeting Drug Delivery to the Brain via Transferrin Anchored Nanoparticles

  2012cites this paper
• Exploiting the properties of biomolecules for brain targeting of nanoparticulate systems.

  2012cites this paper